The COVID-19 vaccine is being produced so quickly due to a combination of factors involving the research community, government, industry and the public.

Emergency authorization means the FDA facilitates availability of the vaccine during a declared state of emergency.

At first, COVID-19 vaccines won’t be marketed in the usual sense, because the government will be the main buyer.

A COVID vaccine from the pharmaceutical company has been shown to be highly promising.

To build public trust, Pfizer shared details of their trials: who was tested, the race and ethnicity of participants, how they were monitored, how to measure success and funding sources.

Pfizer hopes to run with its “little blue pill” as long as it can. That includes the time-honored strategy of launching its own generic.

The Pfizer-Allergan merger is out, but what about inversions across the board?

A change in U.S. tax laws has put a halt to the merger.